Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
AN2 Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/09/2022 |
3
| FitzPatrick Margaret M (Director) has filed a Form 3 on AN2 Therapeutics, Inc. |
| 03/24/2022 |
3
| Krause Kevin Michael (Chief Strategy Officer) has filed a Form 3 on AN2 Therapeutics, Inc. |
| 03/24/2022 |
3
| Spigelman Melvin K (Director) has filed a Form 3 on AN2 Therapeutics, Inc. |
| 03/24/2022 |
3
| Martin Patricia A. (Director) has filed a Form 3 on AN2 Therapeutics, Inc. |
| 03/24/2022 |
3
| Zakrzewski Joseph S (Director) has filed a Form 3 on AN2 Therapeutics, Inc. |
| 03/24/2022 |
3
| Eckburg Paul (Chief Medical Officer) has filed a Form 3 on AN2 Therapeutics, Inc. |
| 03/24/2022 |
3
| Aziz Kabeer (Director) has filed a Form 3 on AN2 Therapeutics, Inc. |
| 03/24/2022 |
3
| Nazak Michael Adrian (Chief Accounting Officer) has filed a Form 3 on AN2 Therapeutics, Inc. |
| 03/24/2022 |
3
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 3 on AN2 Therapeutics, Inc. |
| 03/24/2022 |
3
| Marks Gilbert Lynn (Director) has filed a Form 3 on AN2 Therapeutics, Inc. |
| 03/24/2022 |
3
| Readnour Robin Shane (Director) has filed a Form 3 on AN2 Therapeutics, Inc. |
| 03/24/2022 |
3
| Day Lucy (CFO) has filed a Form 3 on AN2 Therapeutics, Inc. |
| 03/24/2022 |
3
| Easom Eric (CEO) has filed a Form 3 on AN2 Therapeutics, Inc. |
| 03/24/2022 |
3
| Chanda Sanjay (Chief Development Officer) has filed a Form 3 on AN2 Therapeutics, Inc. |
| 03/24/2022 |
3
| Adjuvant Global Health Technology Fund, L.P. (10% Owner) has filed a Form 3 on AN2 Therapeutics, Inc. |
| 03/24/2022 |
3
| Wong Stephanie (Director) has filed a Form 3 on AN2 Therapeutics, Inc. |
|
|